Skip to main

OpGen

OPGN is nowCFOR
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More

Frequently Asked Questions (FAQ)

As of Mar 22, 2026, the market cap for OpGen stock is $291.19M

The current P/E ratio for OpGen stock is 59.8

The 52-week high for OpGen stock is $34. The current OpGen stock price $undefined is 100.00% below its 52-week high

No, the OpGen stock does not pay dividends to its shareholders

How to buy OpGen stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in OpGen stock

    Navigate to the Explore page. Then, type OpGen into the search bar. When you see OpGen stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased OpGen stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.

OpGen Stock Earnings

The value each OPGN share was expected to gain vs. the value that each OPGN share actually gained.

OpGen (OPGN) reported Q3 2023 earnings per share (EPS) of -$4.60, missing estimates of -$4.30 by 6.98%. In the same quarter last year, OpGen's earnings per share (EPS) was -$60. OpGen is expected to release next earnings on , with an earnings per share (EPS) estimate of $0.

Buy OpGen (OPGN) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.